Skip to main content
Top
Published in: AIDS and Behavior 3/2010

01-06-2010 | Original Paper

Efficacy of a Single-Session HIV Prevention Intervention for Black Women: A Group Randomized Controlled Trial

Authors: Dázon Dixon Diallo, Trent Wade Moore, Paulyne M. Ngalame, Lisa Diane White, Jeffrey H. Herbst, Thomas M. Painter

Published in: AIDS and Behavior | Issue 3/2010

Login to get access

Abstract

SisterLove Inc., a community-based organization (CBO) in Atlanta, Georgia, evaluated the efficacy of its highly interactive, single-session HIV prevention intervention for black women, the Healthy Love Workshop (HLW). HLW is delivered to pre-existing groups of women (e.g., friends, sororities) in settings of their choosing. Eligible groups of women were randomly assigned to receive the intervention (15 groups; 161 women) or a comparison workshop (15 groups; 152 women). Behavioral assessments were conducted at baseline and at 3- and 6-month follow-ups. Among sexually active women at the 3-month follow-up, HLW participants were more likely than comparison participants to report having used condoms during vaginal sex with any male partner or with a primary male partner, and to have used condoms at last vaginal, anal or oral sex with any male partner. At the 6-month follow-up, HLW participants were more likely to report condom use at last vaginal, anal or oral sex with any male partner, and having an HIV test and receiving their test results. The study findings suggest that a single-session intervention delivered to pre-existing groups of black women is an efficacious approach to HIV prevention. This study also demonstrates that a CBO can develop and deliver a culturally appropriate, effective HIV prevention intervention for the population it serves and, with adequate resources and technical assistance, rigorously evaluate its intervention.
Literature
1.
go back to reference U.S. Census Bureau. Table DP-1 General Demographic Characteristics, Data set 2007 Population Estimates. Washington, DC: U.S. Census Bureau, Population Estimates Program; 2007. U.S. Census Bureau. Table DP-1 General Demographic Characteristics, Data set 2007 Population Estimates. Washington, DC: U.S. Census Bureau, Population Estimates Program; 2007.
3.
go back to reference McQuillan GM, Khare M, Karon JM, Schable CA, Vlahov D. Update on the seroepidemiology of human immunodeficiency virus in the United states household population: NHANES III, 1988–1994. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:355–60.PubMed McQuillan GM, Khare M, Karon JM, Schable CA, Vlahov D. Update on the seroepidemiology of human immunodeficiency virus in the United states household population: NHANES III, 1988–1994. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:355–60.PubMed
4.
go back to reference McQuillan GM, Kruszon-Moran D. HIV infection in the United States household population aged 18–49 years: results from 1999–2006. NCHS Data Brief No. 4. Hyattsville: National Center for Health Statistics, Centers for Disease Control and Prevention; 2008. McQuillan GM, Kruszon-Moran D. HIV infection in the United States household population aged 18–49 years: results from 1999–2006. NCHS Data Brief No. 4. Hyattsville: National Center for Health Statistics, Centers for Disease Control and Prevention; 2008.
5.
go back to reference Centers for Disease Control and Prevention. HIV/AIDS surveillance, year-end edition. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 1990. Centers for Disease Control and Prevention. HIV/AIDS surveillance, year-end edition. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 1990.
6.
go back to reference Hall HI, An Q, Hutchinson AB, Sansom S. Estimating the lifetime risk of a diagnosis of the HIV infection in 33 states, 2004–2005. J Acquir Immune Defic Syndr. 2008;49(3):294–7.CrossRefPubMed Hall HI, An Q, Hutchinson AB, Sansom S. Estimating the lifetime risk of a diagnosis of the HIV infection in 33 states, 2004–2005. J Acquir Immune Defic Syndr. 2008;49(3):294–7.CrossRefPubMed
7.
go back to reference Centers for Disease Control and Prevention. Deaths: leading causes for 1999. Hyattsville: National Center for Health Statistics, Centers for Disease Control and Prevention; 1999. Centers for Disease Control and Prevention. Deaths: leading causes for 1999. Hyattsville: National Center for Health Statistics, Centers for Disease Control and Prevention; 1999.
9.
go back to reference Anderson RN, Smith BL. Deaths: leading causes for 2001. Natl Vital Stat Rep. 2003;52(9):1–85. Anderson RN, Smith BL. Deaths: leading causes for 2001. Natl Vital Stat Rep. 2003;52(9):1–85.
10.
go back to reference Anderson RN, Smith BL. Leading causes of death in females, deaths: leading causes for 2002. Natl Vital Stat Rep. 2005;53(17):1–89.PubMed Anderson RN, Smith BL. Leading causes of death in females, deaths: leading causes for 2002. Natl Vital Stat Rep. 2005;53(17):1–89.PubMed
11.
go back to reference Reif S, Geonnotti KL, Whetten K. HIV infection and AIDS in the Deep South. Am J Public Health. 2006;96(6):970–3.CrossRefPubMed Reif S, Geonnotti KL, Whetten K. HIV infection and AIDS in the Deep South. Am J Public Health. 2006;96(6):970–3.CrossRefPubMed
12.
go back to reference Adimora AA, Schoenbach VJ, Doherty IA. HIV and African Americans in the southern United States: sexual networks and social context. Sex Transm Dis. 2006;33(Suppl. 7):S39–45.PubMed Adimora AA, Schoenbach VJ, Doherty IA. HIV and African Americans in the southern United States: sexual networks and social context. Sex Transm Dis. 2006;33(Suppl. 7):S39–45.PubMed
14.
go back to reference Jemmott LS, Jemmott JB III, O’Leary A. Effects on sexual risk behavior and STD rate of brief HIV/STD prevention interventions for African American women in primary care settings. Am J Public Health. 2007;97:1034–40.CrossRefPubMed Jemmott LS, Jemmott JB III, O’Leary A. Effects on sexual risk behavior and STD rate of brief HIV/STD prevention interventions for African American women in primary care settings. Am J Public Health. 2007;97:1034–40.CrossRefPubMed
15.
go back to reference Sterk CE, Theall KP, Elifson KW. Effectiveness of a risk reduction intervention among African American women who use crack cocaine. AIDS Educ Prev. 2003;15(1):15–32.CrossRefPubMed Sterk CE, Theall KP, Elifson KW. Effectiveness of a risk reduction intervention among African American women who use crack cocaine. AIDS Educ Prev. 2003;15(1):15–32.CrossRefPubMed
16.
go back to reference Wechsberg WM, Lam WK, Zule WA, Bobashev G. Efficacy of a woman-focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers. Am J Public Health. 2004;94:165–73.CrossRef Wechsberg WM, Lam WK, Zule WA, Bobashev G. Efficacy of a woman-focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers. Am J Public Health. 2004;94:165–73.CrossRef
17.
go back to reference Ehrhardt AA, Exner TM, Hoffman S, et al. A gender-specific HIV/STD risk reduction intervention for women in a health care setting: short- and long-term results of a randomized clinical trial. AIDS Care. 2002;14:147–61.CrossRefPubMed Ehrhardt AA, Exner TM, Hoffman S, et al. A gender-specific HIV/STD risk reduction intervention for women in a health care setting: short- and long-term results of a randomized clinical trial. AIDS Care. 2002;14:147–61.CrossRefPubMed
18.
go back to reference Hobfoll SE, Jackson AP, Lavin J, Johnson RJ, Schroder KEE. Effects and generalizability of communally oriented HIV-AIDS prevention versus general health promotion groups for single, inner-city women in urban clinics. J Consult Clin Psychol. 2002;70(4):950–60.CrossRefPubMed Hobfoll SE, Jackson AP, Lavin J, Johnson RJ, Schroder KEE. Effects and generalizability of communally oriented HIV-AIDS prevention versus general health promotion groups for single, inner-city women in urban clinics. J Consult Clin Psychol. 2002;70(4):950–60.CrossRefPubMed
19.
go back to reference Wingood GM, DiClemente RJ, Mikhail I, et al. A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: the WiLLOW program. J Acquir Immune Defic Syndr. 2004;37:S58–67.CrossRefPubMed Wingood GM, DiClemente RJ, Mikhail I, et al. A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: the WiLLOW program. J Acquir Immune Defic Syndr. 2004;37:S58–67.CrossRefPubMed
21.
go back to reference Lyles CM, Kay LS, Crepaz N, et al. Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000–2004. Am J Public Health. 2007;97:133–43.CrossRefPubMed Lyles CM, Kay LS, Crepaz N, et al. Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000–2004. Am J Public Health. 2007;97:133–43.CrossRefPubMed
22.
go back to reference DiClemente RJ, Wingood GM. A randomized controlled trial of an HIV sexual risk reduction intervention for young African American women. JAMA. 1995;274(16):1271–6.CrossRefPubMed DiClemente RJ, Wingood GM. A randomized controlled trial of an HIV sexual risk reduction intervention for young African American women. JAMA. 1995;274(16):1271–6.CrossRefPubMed
23.
go back to reference Collins C, Harshbarger C, Sawyer R, Hamdallah M. The diffusion of effective behavioral interventions project: development, implementation, and lessons learned. AIDS Educ Prev. 2006;18(Suppl. A): 5–20. Collins C, Harshbarger C, Sawyer R, Hamdallah M. The diffusion of effective behavioral interventions project: development, implementation, and lessons learned. AIDS Educ Prev. 2006;18(Suppl. A): 5–20.
25.
go back to reference Centers for Disease Control and Prevention. Evaluation of innovative human immunodeficiency virus (HIV) prevention interventions for high-risk minority populations. Fed Register 2004;69(134): 42183–190. Centers for Disease Control and Prevention. Evaluation of innovative human immunodeficiency virus (HIV) prevention interventions for high-risk minority populations. Fed Register 2004;69(134): 42183–190.
26.
go back to reference Becker MH. The health belief model and personal health behavior. Health Educ Monographs. 1974;2:324–473. Becker MH. The health belief model and personal health behavior. Health Educ Monographs. 1974;2:324–473.
27.
go back to reference Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12:38–48.PubMed Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12:38–48.PubMed
28.
go back to reference Bandura A. Social cognitive theory in cultural context. Appl Psychol Int Rev. 2003;51:269–91.CrossRef Bandura A. Social cognitive theory in cultural context. Appl Psychol Int Rev. 2003;51:269–91.CrossRef
29.
go back to reference Sillman J, Fried MG, Ross L, Gutiérrez ER. Undivided rights: women of color organize for reproductive justice. Cambridge: South End Press; 2004. Sillman J, Fried MG, Ross L, Gutiérrez ER. Undivided rights: women of color organize for reproductive justice. Cambridge: South End Press; 2004.
30.
go back to reference Rietmeijer CA, Fichtner RR. Toward a behavioral surveillance system for HIV/STD prevention. Atlanta: National HIV Prevention Conference; 1999. Rietmeijer CA, Fichtner RR. Toward a behavioral surveillance system for HIV/STD prevention. Atlanta: National HIV Prevention Conference; 1999.
31.
go back to reference Carey MP, Schroder KEE. Development and psychometric evaluation of a brief HIV knowledge questionnaire. AIDS Educ Prev. 2002;14:174–84. Carey MP, Schroder KEE. Development and psychometric evaluation of a brief HIV knowledge questionnaire. AIDS Educ Prev. 2002;14:174–84.
32.
go back to reference DeHart DD, Birkimer JC. Trying to practice safer sex: development of the sexual risks scale. J Sex Research. 1997;34:11–25.CrossRef DeHart DD, Birkimer JC. Trying to practice safer sex: development of the sexual risks scale. J Sex Research. 1997;34:11–25.CrossRef
33.
go back to reference Brafford LJ, Beck KH. Development and validation of a condom self-efficacy scale for college students. J Am Coll Health. 1991;39:219–25.PubMed Brafford LJ, Beck KH. Development and validation of a condom self-efficacy scale for college students. J Am Coll Health. 1991;39:219–25.PubMed
34.
go back to reference Grimley DM, Prochaska JO, Velicer WF, Prochaska GE. Contraception and condom use adoption and maintenance: a stage paradigm approach. Health Educ Q. 1995;22(1):20–35.PubMed Grimley DM, Prochaska JO, Velicer WF, Prochaska GE. Contraception and condom use adoption and maintenance: a stage paradigm approach. Health Educ Q. 1995;22(1):20–35.PubMed
35.
go back to reference Varnell SP, Murray DM, Janega JB, Blitstein JL. Design and analysis of group-randomized trials: a review of recent practices. Am J Public Health. 2004;94:393–9.CrossRefPubMed Varnell SP, Murray DM, Janega JB, Blitstein JL. Design and analysis of group-randomized trials: a review of recent practices. Am J Public Health. 2004;94:393–9.CrossRefPubMed
36.
go back to reference Lyles CM, Crepaz N, Herbst JH, Kay LS. Evidence-based HIV behavioral prevention from the perspective of CDC’s HIV/AIDS Prevention Research Synthesis Team. AIDS Educ Prev. 2006;18(Suppl. A): 21–31. Lyles CM, Crepaz N, Herbst JH, Kay LS. Evidence-based HIV behavioral prevention from the perspective of CDC’s HIV/AIDS Prevention Research Synthesis Team. AIDS Educ Prev. 2006;18(Suppl. A): 21–31.
37.
go back to reference StataCorp. Stata Statistical Software, Release 8. In: College Station: StataCorp LP; 2003. StataCorp. Stata Statistical Software, Release 8. In: College Station: StataCorp LP; 2003.
38.
go back to reference Crepaz N, Marshall KJ, Aupont LW, et al. The efficacy of HIV/STI behavioral interventions for African-American females in the United States: a meta-analysis. Am J Public Health. 2009;99(11):2069–78.CrossRefPubMed Crepaz N, Marshall KJ, Aupont LW, et al. The efficacy of HIV/STI behavioral interventions for African-American females in the United States: a meta-analysis. Am J Public Health. 2009;99(11):2069–78.CrossRefPubMed
39.
go back to reference Darbes L, Crepaz N, Lyles C, Kennedy G, Rutherford G. The efficacy of behavioral interventions in reducing HIV risk behaviors and incident sexually transmitted diseases in heterosexual African Americans. AIDS. 2008;22:1177–94.CrossRefPubMed Darbes L, Crepaz N, Lyles C, Kennedy G, Rutherford G. The efficacy of behavioral interventions in reducing HIV risk behaviors and incident sexually transmitted diseases in heterosexual African Americans. AIDS. 2008;22:1177–94.CrossRefPubMed
40.
go back to reference Wingood GM, DiClemente RJ. HIV sexual risk reduction interventions for women: a review. Am J Prev Med. 1996;12(3):209–17.PubMed Wingood GM, DiClemente RJ. HIV sexual risk reduction interventions for women: a review. Am J Prev Med. 1996;12(3):209–17.PubMed
41.
go back to reference Beatty LA, Wheeler D, Gaiter J. HIV prevention research for African Americans: current and future directions. J Black Psychol. 2004;30(1):40–58.CrossRef Beatty LA, Wheeler D, Gaiter J. HIV prevention research for African Americans: current and future directions. J Black Psychol. 2004;30(1):40–58.CrossRef
42.
go back to reference Johnson BT, Scott-Sheldon LAJ, Smoak ND, LaCroix JM, Anderson JR, Carey MP. Behavioral interventions for African Americans to reduce sexual risk of HIV: a meta-analysis of randomized controlled trials. J Acquir Immune Defic Syndr. 2009;51(4):492–501.CrossRefPubMed Johnson BT, Scott-Sheldon LAJ, Smoak ND, LaCroix JM, Anderson JR, Carey MP. Behavioral interventions for African Americans to reduce sexual risk of HIV: a meta-analysis of randomized controlled trials. J Acquir Immune Defic Syndr. 2009;51(4):492–501.CrossRefPubMed
43.
go back to reference Eldridge S, Ashby D, Bennett C, Wakelin M, Feder G. Internal and external validity of cluster randomised trials: systematic review of recent trials. BMJ. 2008;336(7649):876–80.CrossRefPubMed Eldridge S, Ashby D, Bennett C, Wakelin M, Feder G. Internal and external validity of cluster randomised trials: systematic review of recent trials. BMJ. 2008;336(7649):876–80.CrossRefPubMed
44.
go back to reference Adimora AA, Schoenbach VJ. Social context, sexual networks, and racial disparities in rates of sexually transmitted infections. J Infect Dis. 2005;191(Suppl. 1):S115–22.CrossRefPubMed Adimora AA, Schoenbach VJ. Social context, sexual networks, and racial disparities in rates of sexually transmitted infections. J Infect Dis. 2005;191(Suppl. 1):S115–22.CrossRefPubMed
45.
go back to reference Farley TA. Sexually transmitted diseases in the Southeastern United States: Location, race, and social context. Sex Transm Dis. 2006;33(Suppl. 7):S58–64.PubMed Farley TA. Sexually transmitted diseases in the Southeastern United States: Location, race, and social context. Sex Transm Dis. 2006;33(Suppl. 7):S58–64.PubMed
46.
go back to reference Friedman SR, Cooper HLF, Osborne AH. Structural and social contexts of HIV risk among African Americans. Am J Public Health. 2009;99(6):1002–8.CrossRefPubMed Friedman SR, Cooper HLF, Osborne AH. Structural and social contexts of HIV risk among African Americans. Am J Public Health. 2009;99(6):1002–8.CrossRefPubMed
47.
go back to reference Hallfors DD, Iritani BJ, Miller WC, Bauer DJ. Sexual and drug behavior patterns and HIV and STD racial disparities: the need for new directions. Am J Public Health. 2007;97(1):125–32.CrossRefPubMed Hallfors DD, Iritani BJ, Miller WC, Bauer DJ. Sexual and drug behavior patterns and HIV and STD racial disparities: the need for new directions. Am J Public Health. 2007;97(1):125–32.CrossRefPubMed
48.
go back to reference Burton J, Darbes LA, Operario D. Couples-focused behavioral interventions for prevention of HIV: systematic review of the state of evidence. AIDS Behav 2009; E-published. doi:10.1007/s10461-008=9471-4. Burton J, Darbes LA, Operario D. Couples-focused behavioral interventions for prevention of HIV: systematic review of the state of evidence. AIDS Behav 2009; E-published. doi:10.​1007/​s10461-008=​9471-4.
49.
go back to reference El-Bassel N, Caldeira NA, Ruglass LM, Gilbert L. Addressing the unique needs of African American women in HIV prevention. Am J Public Health. 2009;99(6):996–1001.CrossRefPubMed El-Bassel N, Caldeira NA, Ruglass LM, Gilbert L. Addressing the unique needs of African American women in HIV prevention. Am J Public Health. 2009;99(6):996–1001.CrossRefPubMed
50.
go back to reference Morris M, Kurth AE, Hamilton DT, Moody J, Wakefield S. Concurrent partnerships and HIV prevalence disparities by race: linking science and public health practice. Am J Public Health. 2009;99(6):1023–31.CrossRefPubMed Morris M, Kurth AE, Hamilton DT, Moody J, Wakefield S. Concurrent partnerships and HIV prevalence disparities by race: linking science and public health practice. Am J Public Health. 2009;99(6):1023–31.CrossRefPubMed
51.
go back to reference Purcell DW, McCree DH. Recommendations from a research consultation to address intervention strategies for HIV/AIDS prevention focused on African Americans. Am J Public Health. 2009;99(11):1937–40.CrossRefPubMed Purcell DW, McCree DH. Recommendations from a research consultation to address intervention strategies for HIV/AIDS prevention focused on African Americans. Am J Public Health. 2009;99(11):1937–40.CrossRefPubMed
Metadata
Title
Efficacy of a Single-Session HIV Prevention Intervention for Black Women: A Group Randomized Controlled Trial
Authors
Dázon Dixon Diallo
Trent Wade Moore
Paulyne M. Ngalame
Lisa Diane White
Jeffrey H. Herbst
Thomas M. Painter
Publication date
01-06-2010
Publisher
Springer US
Published in
AIDS and Behavior / Issue 3/2010
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9672-5

Other articles of this Issue 3/2010

AIDS and Behavior 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine